Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

b338ae26adf5.K6vRTUAF4PTTIMqoNP3eKZr31PS_fp52SUS2fReawXw.XPyXAw5dlMSSSP7ca7eQHqiclrbqR-gFDHThJCPdqglgw4V8GjW1h-BupQ~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +61.9%
+3.53%
+3.09%
-0.98%
-2.95%
+13.36%
-1.36%
+23.73%
-12.06%
+0.62%
Average +8.89%
Weighted average by Cap. +3.00%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
315.00PKR
Average target price
510.00PKR
Spread / Average Target
+61.90%
High Price Target
510.00PKR
Spread / Highest target
+61.90%
Low Price Target
510.00PKR
Spread / Lowest Target
+61.90%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited